- Report
- July 2024
- 39 Pages
China
From €4546EUR$4,995USD£3,861GBP
- Report
- July 2024
- 38 Pages
South Korea
From €4546EUR$4,995USD£3,861GBP
- Report
- July 2024
- 37 Pages
Russia
From €4546EUR$4,995USD£3,861GBP
- Report
- July 2024
- 37 Pages
Spain
From €4546EUR$4,995USD£3,861GBP
- Report
- July 2024
- 39 Pages
Italy
From €4546EUR$4,995USD£3,861GBP
- Report
- July 2024
- 36 Pages
United Kingdom
From €4546EUR$4,995USD£3,861GBP
- Report
- October 2024
- 260 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
The Intra Aortic Balloon (IAB) is a device used in the treatment of cardiovascular diseases. It is a balloon-tipped catheter that is inserted into the aorta and inflated and deflated in a synchronized manner with the patient's heartbeat. This helps to increase the amount of blood flow to the heart, reducing the workload of the heart and improving the patient's condition. The IAB market is a subset of the larger cardiovascular device market, which includes a variety of products used to diagnose and treat cardiovascular diseases.
The IAB market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate in the coming years, driven by the increasing demand for advanced medical devices and the growing awareness of the benefits of IABs.
Some of the major players in the IAB market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and Terumo Corporation. Show Less Read more